Umbilical Cord Tissue being used to treat Multiple Sclerosis

Umbilical Cord Tissue being used to treat Multiple Sclerosis

Translational Biosciences, a subsidiary of Medistem Panama, has received the green light for a phase I/II clinical trial using human umbilical cord-derived mesenchymal stem cells (UC-MSC) for multiple sclerosis from the Comité Nacional de Bioética de la Investigación (CNEI) Institutional Review Board (IRB).

Multiple Sclerosis

Mesenchymal stem cells harvested from donated human umbilical cord tissue after normal, healthy births possess anti-inflammatory and immune modulatory properties that may relieve MS symptoms. Because these cells are immune privileged, the recipient’s immune system does not reject them. These properties make UC-MSC interesting candidates for the treatment of multiple sclerosis and other autoimmune disorders.

Leave a Reply